Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Revenue

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for NATH BIOGENES (INDIA)
Please provide your vote to see the results

NATH BIOGENES (INDIA) Last 5 Year Revenue History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Net Sales ₹365 Cr₹333 Cr₹301 Cr₹278 Cr₹138 Cr

What is the latest Revenue of NATH BIOGENES (INDIA) ?

The latest Revenue ratio of NATH BIOGENES (INDIA) is ₹365 Cr based on Mar2025 Consolidated results.
Year Revenue
Mar2025₹365 Cr
Mar2024₹333 Cr
Mar2023₹301 Cr
Mar2022₹278 Cr
Mar2013₹138 Cr

How is Revenue of NATH BIOGENES (INDIA) Trending?

Years Revenue % Change
Mar2025 ₹365 Cr
9.71
Mar2024 ₹333 Cr
10.37
Mar2023 ₹301 Cr
8.26
Mar2022 ₹278 Cr
102.15
Mar2013 ₹138 Cr -

Compare Revenue of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹288.9 Cr 7.4% -8.5% -23.9% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹13,123.8 Cr 1.7% -0.5% -21.3% Stock Analytics
KAVERI SEED COMPANY ₹4,999.1 Cr -0.6% -5.3% 2.8% Stock Analytics
VENKYS (INDIA) ₹2,032.0 Cr 8.4% 8.2% -14.7% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,021.7 Cr -4.5% -17.4% -39.8% Stock Analytics
INDO US BIOTECH ₹251.5 Cr -2.3% -6.5% -56.1% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

7.4%

-8.5%

-23.9%

SENSEX

-0.5%

1.1%

3.8%


You may also like the below Video Courses